Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2024-10-07 Share Issue/Capital Cha…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2024
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly report on movements in securities, specifically focusing on changes in authorised share capital, issued shares, treasury shares, and repurchase activities for PW Medtech Group Limited. It includes confirmations pursuant to Hong Kong Exchange Listing Rules and detailed tables of share movements and repurchases. The document is not a financial report like an annual or interim report, nor is it a call transcript or management report. It is a regulatory filing related to share capital and treasury shares movements, which fits the category of Share Issue/Capital Change (SHA). The document length is 9379 characters, indicating it is a full report rather than a brief announcement. Therefore, the classification is Share Issue/Capital Change (SHA).
2024-10-07 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, treasury shares, and confirmations of compliance with listing rules. The content is focused on reporting share repurchase activity and changes in share capital rather than announcing a new share issue or capital restructuring. This matches the description of a 'Transaction in Own Shares' filing, which covers company buybacks or sales of its own shares. The document is substantive and detailed, not a brief announcement or a certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA). Therefore, the correct classification is POS (Transaction in Own Shares).
2024-10-04 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and details changes in issued shares and treasury shares, including share repurchases and treasury share sales. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) related to disclosure of share changes. The content includes detailed tables of share repurchases, prices, dates, and confirmations of compliance with listing rules. There is no financial performance data, earnings information, or management discussion. The document is a regulatory disclosure about share transactions and repurchases, fitting the category of Transaction in Own Shares (POS). The length and detail confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is POS with high confidence.
2024-10-03 English
PROGRESS ON PROPOSED SPIN-OFF OF SICHUAN RUIJIAN MEDICAL
Capital/Financing Update Classification · 95% confidence The document is an announcement from PW Medtech Group Limited providing an update on the progress of a proposed spin-off of its subsidiary Sichuan Ruijian Medical. It references previous announcements and regulatory approvals related to the spin-off and potential subsequent listing. The document is relatively short (3808 characters) and serves to inform shareholders and investors about the status and next steps of the spin-off process. It does not contain financial statements, detailed financial analysis, or comprehensive report content. It is clearly an announcement updating on a capital restructuring event (spin-off and listing). Therefore, it fits best under Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through the spin-off and listing process.
2024-10-02 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, treasury shares, and confirmations of compliance with listing rules. The content is focused on reporting share repurchase activity and changes in capital structure rather than financial results, management changes, or other report types. This matches the definition of a 'Transaction in Own Shares' filing, which covers company buybacks or sales of its own shares. The document length and detail confirm it is the report itself, not just an announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2024-10-02 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and details changes in issued shares and treasury shares, including share repurchases and on-market sales. It references compliance with listing rules of the Hong Kong Stock Exchange (Main Board Rules and GEM Rules). The content includes detailed tables of share repurchases, prices, dates, and confirmations of compliance with regulatory requirements. There is no indication of financial statements, earnings data, or management discussion. The document is a regulatory disclosure about share capital changes, specifically share repurchases and treasury share transactions. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2024-09-30 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.